Latest Breaking News On - Rohan palekar - Page 3 : vimarsana.com

89bio (NASDAQ:ETNB) Given Buy Rating at HC Wainwright

89bio (NASDAQ:ETNB – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a research report issued on Wednesday, Benzinga reports. They currently have a $31.00 price target on the stock. HC Wainwright’s target price would suggest a potential upside of 171.45% from the company’s previous close. ETNB has been […]

Nova scotiaRohan palekarFrazier life sciences managementCantor fitzgeraldSecurities exchange commissionRoyal bankBlackrock incCompany profileGet free reportExchange commissionDirector ra capital managementStreet corp

89bio (NASDAQ:ETNB) Stock Rating Reaffirmed by HC Wainwright

89bio (NASDAQ:ETNB – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a research report issued to clients and investors on Wednesday, Benzinga reports. They presently have a $31.00 price objective on the stock. HC Wainwright’s price target would suggest a potential upside of 171.45% from the […]

Rohan palekarAlpine global managementCantor fitzgeraldCharles schwab investment management incCompany profileMarshall waceSecurities exchange commissionRoyal bankEagle asset management incWestfield capital management coGet free reportDirector ra capital managementExchange commissionSchwab investment managementCapital managementAsset management

89bio (ETNB) – Analysts Recent Ratings Changes

89bio (NASDAQ: ETNB) has recently received a number of price target changes and ratings updates: 3/6/2024 – 89bio had its price target raised by analysts at Evercore ISI from $29.00 to $37.00. They now have an “outperform” rating on the stock. 3/5/2024 – 89bio had its “market perform” rating reaffirmed by analysts at Oppenheimer Holdings […]

Rohan palekarWetzel investment advisors incUs bancorpRoyal bankCantor fitzgeraldInc dailyAcadian asset managementOppenheimer holdings incGet free reportDirector ra capital managementInvestment advisorsAsset managementForest capital management89bio incNasdaq etnb

89bio, Inc (NASDAQ:ETNB) CEO Sells $48,172 52 in Stock

89bio, Inc (NASDAQ:ETNB) CEO Sells $48,172 52 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Rohan palekarRoyal bankAcadian asset managementCompany profileUs bancorpWetzel investment advisors incGet free reportInvestment advisorsAsset managementForest capital management

89bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates

– Plan to initiate the Phase 3 ENLIGHTEN NASH program for non-cirrhotic and cirrhotic patients in the first and second quarters of 2024, respectively – – Long-term data from Phase 2b.

San franciscoUnited statesSheryl seapyRohan palekarAnnie changDrug administrationUs food drug administrationLifesci advisorsDevelopment rd expensesExchange commissionEuropean medicines agencyAmerican associationLiver diseases the meetingChief executive officerBreakthrough therapy designationAnnual report